That's correct. I had some other info on uptake etc, but cant find it. I do recall not all patients go on it [But assume most do] also 14% discontinue it's use due to side effects.
Riluzole, extends life expectancy by up to 9 months so any drug that replaces Riluzole as the preferred treatment would need to extend that. Any increase in life expectancy would result in a similar increase in revenue, as they continue taking the drug longer. That's assuming similar cost of treatment of-course.
Cheers
That's correct. I had some other info on uptake etc, but cant...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $38.48K | 213.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 254407 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 55253 | 4 |
View Market Depth
| Last trade - 11.07am 27/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |